EVAR术后动脉瘤扩大的动脉瘤缝合术中远期结果
本研究回顾性纳入2016至2021年50例因II型或V型内漏导致动脉瘤扩大而接受动脉瘤缝合术的EVAR术后患者,术中死亡率为0%,5年生存率和免于再干预率分别为90%和92%,但5年免于动脉瘤再扩大率仅84%,残余内漏和死腔面积是再扩大的显著预测因素,死腔阈值70%以上再扩大风险显著增加。
要点
- 动脉瘤缝合术围手术期死亡率0%,术中并发症率6%,术后并发症率12%。
- 5年生存率90%,免于再干预率92%,免于动脉瘤再扩大率84%。
- 残余内漏和死腔面积是再扩大的显著预测因素,死腔阈值70%。
核心结论
- 动脉瘤缝合术是EVAR术后动脉瘤扩大患者替代人工血管置换的可行选择,尤其适用于高风险患者。
- 再扩大风险仍然关键,尤其当死腔减少不充分时。
- 仔细的患者选择和进一步研究可优化长期结果。
研究设计与样本
- 回顾性研究,纳入2016至2021年50例EVAR术后接受动脉瘤缝合术的患者。
- 手术指征为II型或V型内漏导致的动脉瘤扩大。
- 手术采用经腹膜入路,打开瘤囊、清除血栓、折叠缝合,不置换人工血管。
- 比较术中内漏诊断与术前CT findings。
- 采用Kaplan-Meier分析和logistic回归评估生存、再干预和再扩大危险因素。
主要发现
- 术中并发症率6%,围手术期死亡率0%,术后并发症率12%。
- 与术前CT findings相比,13例(26%)诊断发生改变。
- 初诊为单纯II型内漏的病例中,2例合并Ib型内漏,7例为IIIb型内漏。
- 平均随访4.5年,5年生存率90%,免于再干预率92%。
- 5年免于动脉瘤再扩大率仅84%;残余内漏和死腔面积是再扩大的显著预测因素。
关键数值与推荐
- ROC分析确定死腔阈值为70%,高于此阈值再扩大风险显著增加。
临床怎么用
- 对于EVAR术后因II型或V型内漏导致动脉瘤扩大的高风险患者,动脉瘤缝合术可作为人工血管置换的替代选择。
- 术中应关注残余内漏和死腔减少程度,死腔阈值70%以上再扩大风险显著增加。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Although endovascular aneurysm repair (EVAR) is a standard treatment for abdominal aortic aneurysms, postprocedural aneurysm expansion caused by types II and V endoleaks (ELs) remains challenging. Aortic graft replacement is a definitive solution, but is associated with high morbidity and mortality, especially in elderly patients. Aneurysmorrhaphy has emerged as a less invasive alternative. This study evaluated the midterm outcomes of aneurysmorrhaphy after EVAR and identified factors associated with aneurysm re-expansion. METHODS: This retrospective study included 50 patients who underwent aneurysmorrhaphy after EVAR from 2016 to 2021. Indications included aneurysm expansion owing to type II or V ELs. Surgery was performed using a transperitoneal approach with aneurysm sac opening, thrombus removal, and plication without graft replacement. Intraoperative EL diagnosis and preoperative computed tomography findings were compared. Survival, reintervention, and risk factors for re-expansion were assessed by Kaplan-Meier analysis and logistic regression. RESULTS: The intraoperative morbidity rate was 6%, the perioperative mortality rate was 0%, and the postoperative morbidity rate was 12%. Compared with preoperative computed tomography findings, the diagnosis was changed in 13 cases (26%). Among the cases initially diagnosed as type II EL alone, two cases had concomitant type Ib EL, and seven cases were type IIIb EL. The mean follow-up period was 4.5 years. The 5-year survival and reintervention-free rates were 90% and 92%, respectively. Notably, the 5-year freedom from aneurysm re-expansion rate was only 84%. Residual ELs and dead space areas were notable predictors of re-expansion. Receiver operating characteristic analysis identified a dead space threshold of 70%, above which re-expansion risk was significantly greater. CONCLUSIONS: Aneurysmorrhaphy is a viable alternative to graft replacement for post-EVAR aneurysm expansion, especially in high-risk patients. However, the risk of re-expansion remains critical, particularly when dead space reduction is inadequate. Careful patient selection and further research can optimize long-term outcomes.
引用
- Wada Y, Takagi Y, Chino S, et al. Midterm results of aneurysmorrhaphy for enlargement after endovascular aneurysm repair. J Vasc Surg. 2025. PMID: 40712844. doi:10.1016/j.jvs.2025.07.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。